A Win For Ra Medical Systems, Inc.

Ra Medical Systems, Inc. (RMED:NYSE) shot up at $2.03, a gain of 29.3%. On Tue 14 Jan 20, RMED:NYSE hit a New 2-Week High of $1.57. From Mon 23 Dec 19, the stock recorded 64.29% Up Days and 53.33% Green Days

About Ra Medical Systems, Inc. (RMED:NYSE)

Ra Medical Systems Inc is a commercial-stage medical device company. It is engaged in designing, developing, and commercialization of excimer lasers for the treatment of dermatologic and cardiovascular diseases. The company's products include DABRA and Pharos. DABRA System is an effective, and versatile catheter and excimer laser system for the treatment of complex and diffuse arterial blockages in the lower vessels, and the Pharos is a monochromatic, xenon-chlorine, 308-nm UVB excimer laser for the treatment of difficult-to-treat, chronic diseases including psoriasis and vitiligo. Its business segments are the Dermatology segment and the Vascular segment. Generating, its revenue from the Dermatology segment.